I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

I am a healthcare professional in Canada

Required field.

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Ophthalmology ASRS 2026
Roche and Genentech at

ASRS 2026

July 15 - July 18
Montreal, Canada
asrs.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
12:00 PM
Duration 8mins Montreal, Canada
Outcomes for Continuous Ranibizumab Delivery via the Port Delivery Platform in Diabetic Eyes Undergoing Vitrectomy for Vitreous Hemorrhage
Dennis Marcus
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
Port Delivery Platform With Ranibizumab Treatment in Eyes With Neovascular Age-Related Macular Degeneration and High Injection Burden
Jeffrey Moore
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
Retinal Fluid, Thickness Fluctuations, and Vascular Leakage in the Port Delivery Platform with Ranibizumab in Study Eyes vs Anti-VEGF Injections in Fellow Eyes in Bilateral Diabetic Macular Edema in the Pagoda Trial
Robert Wirthlin
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
Low Risk of Proliferative Vision-Threatening Complications Observed in Patients with Diabetic Eye Disease Treated with Continuous Delivery via the Port Delivery Platform with Ranibizumab
Manjot Gill
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
Five-Year Retinal Fluid Outcomes in PDS-Treated Patients With Neovascular Age-Related Macular Degeneration Enrolled in the Archway-to-Portal Trials
Caesar Luo
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
The Molecular Pathophysiology Of Uveitic Macular Edema: An Exploratory Analysis From The DOVETAIL Vamikibart Phase 1 Study
Steven Yeh
Ophthalmology | Uveitic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
Efficacy and Safety of Vamikibart in Patients With Uveitic Macular Edema: Pooled Results of the Phase 3 MEERKAT and SANDCAT Trials
Glenn J. Jaffe
Ophthalmology | Uveitic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
Real-World Persistence, Switching, and Reinitiation in Patients Who Are on Faricimab▼ in US and Their Clinical Outcomes
Basil Williams
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
Measuring the Diabetic Eye Disease Care Continuum — Who Is Falling Through the Care Gaps?
Shriji Patel
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
Clinical and Economic Impact of Faricimab▼ -Treated Diabetic Macular Edema Patients: A Linked Analysis of Administrative Claims and IRIS Registry EHR Data
Blake A. Cooper
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
Early Real-World Effectiveness and Safety of Faricimab▼ in Eyes With RVO: 6-Month Results From the UK FARWIDE-RVO Study
Richard P. Gale
Ophthalmology | Retinal Vein Occlusion

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
Visual Outcomes by Age and Sex in Uveitic Macular Edema: Real-World Retina Registry Analysis
Brian K. Do
Ophthalmology | Uveitic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
Vision Gains With Faricimab▼ vs Aflibercept 2 mg in Patients With Treatment-Naïve nAMD Who Had Small Lesions: A TENAYA/LUCERNE Post Hoc Analysis
Amer Omar
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
Reduction in Subretinal Hyperreflective Material With Faricimab▼ vs Aflibercept 2 mg in Treatment-Naïve nAMD
Sean Adrean
Haematology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
Two-Year Real-World Outcomes of Faricimab▼ for Wet Age-Related Macular Degeneration: Updated Results from the FARETINA-nAMD Expanded 2-Year Cohort in the Academy IRIS® Registry
Ferhina S. Ali
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
One-Year Outcomes of Faricimab▼ Patients With nAMD and DME From a Global, Prospective Observational Study: The VOYAGER Study
Aires Lobo
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
Robust Vision Gains and Anatomic Improvements With Faricimab▼ in Patients With Polypoidal Choroidal Vasculopathy: Week 48 Results From SALWEEN
Min Sagong
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 8mins Montreal, Canada
Automated Quantification of Retinal Fluid and Thickness on SD-OCT for Assessing Treatment Response in DME: Biomarker Results From YOSEMITE/RHINE
Bradley T. Smith
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:56 PM
Duration 3mins Montreal, Canada
Long-Term Effectiveness and Safety of Faricimab▼ in Eyes With nAMD: 2-Year Results From the UK FARWIDE Study
Ian Pearce
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:15 PM
Duration 60mins Montreal, Canada
The nAMD evidence arena: Where data meets discussion
Srinivas Sadda, Jennifer Lim, Gabriela Grimaldi, Nirojini Sivachandran
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:12 PM
Duration 30mins Montreal, Canada
Pagoda Trial Results Through Year 4: Port Delivery Platform With Ranibizumab for the Treatment of Diabetic Macular Edema
Luke B. Lindsell
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 3mins Montreal, Canada
Long-Term Effectiveness and Safety of Faricimab▼ in Eyes With DME: 2-Year Results From the UK FARWIDE Study
Sobha Sivaprasad
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:22 PM
Duration 3mins Montreal, Canada
Two-Year Real-World Outcomes of Faricimab▼ for Diabetic Macular Edema: Updated Results From the US FARETINA-DME Expanded Two-Year Cohort in the Academy IRIS® Registry
Murtaza Adam
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:31 PM
Duration 3mins Montreal, Canada
Real-World Clinical Outcomes in Patients With Retinal Vein Occlusion With Macular Edema Treated With Faricimab▼ in the Academy IRIS® Registry
Rishi Singh
Ophthalmology | Retinal Vein Occlusion

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:10 PM
Duration 60mins Montreal, Canada
Baseline Characteristics of Participants With Uveitic Macular Edema in the Vamikibart Phase 3 MEERKAT and SANDCAT Trials
Fortin E, Lim L, Nguyen QD, Acharya N, Pepple K, Khuranan R, Pavesio C, Sonoda KH, Galloway D, Pauly-Evers M, Muzaffar S, Mesquida M, Haskova Z, Silverman D, Vicente A, Steeples L, Suhler E
Ophthalmology | Uveitic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:28 PM
Duration 75mins Montreal, Canada
Turning Evidence Into Experience: The Evolution of Continuous Drug Delivery in Retinal Disease
Dante Pieramici, Margaret Chang, Adam Pflugrath and Deepika Malik
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema - Diabetic Retinopathy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:33 PM
Duration 3mins Montreal, Canada
Baseline Biomarker Levels in Underrepresented Patients With DME: A Post Hoc Exploratory Analysis of ELEVATUM
Adrienne Scott
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 3mins Montreal, Canada
Impact of Social Deprivation and Vulnerability on Patients With DME: Results From ELEVATUM and YOSEMITE/RHINE
Mohsin Ali
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 3mins Montreal, Canada
Real-World Impact of Step-Therapy Requirements on Access to Faricimab▼ and Treatment Burden
Sabin Dang
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:20 PM
Duration 3mins Montreal, Canada
Impact of Baseline Subretinal Fluid on Treatment Outcomes in DME: Analysis of the Phase 3 YOSEMITE and RHINE Trials
Rolake Alabi
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 3mins Montreal, Canada
Quantification of the OCT Biomarker Retinal Fluid in Diabetic Macular Edema Treated With Faricimab▼
Andreas Pollreisz
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:00 PM
Duration 60mins Montreal, Canada
The DME evidence arena: Where data meets discussion
Veeral Sheth, Shaheer Aboobaker, Maria Berrocal, Ian Pearce
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.